Radiation therapy and secondary malignancy in Li‐Fraumeni syndrome: A hereditary cancer registry study

BACKGROUND: Li‐Fraumeni Syndrome (LFS) is a rare cancer‐predisposing condition caused by germline mutations in TP53. Conventional wisdom and prior work has implied an increased risk of secondary malignancy in LFS patients treated with radiation therapy (RT); however, this risk is not well‐characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendrickson, Peter G., Luo, Yukun, Kohlmann, Wendy, Schiffman, Josh, Maese, Luke, Bishop, Andrew J., Lloyd, Shane, Kokeny, Kristine E., Hitchcock, Ying J., Poppe, Matthew M., Gaffney, David K., Tao, Randa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643676/
https://www.ncbi.nlm.nih.gov/pubmed/32931654
http://dx.doi.org/10.1002/cam4.3427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7643676/
https://www.ncbi.nlm.nih.gov/pubmed/32931654
http://dx.doi.org/10.1002/cam4.3427

Ejemplares similares